(thirdQuint)A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus.

 This study consists of two parts.

 In Part 1, ASP1941 or placebo will be administered orally in a blind manner.

 In Part 2, the long-term safety and efficacy of ASP1941 will be evaluated in patients who have participated in the study and completed the Part 1.

.

 A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus@highlight

The objective of this study is to confirm efficacy of ASP1941 based on the changes in HbA1c and to assess its safety in subjects with type 1 diabetes mellitus receiving ASP1941 once daily in combination with insulin for 24 weeks.

 This study will also assess the safety/efficacy of long-term treatment (52 weeks).

